biote Corp. (BTMD) Income Statement

NASDAQ: BTMDRevenue, profits, margins and EPS over 7 years.

BTMD 2025 at a glance

Fiscal year ended December 31, 2025 · U.S. dollars
Revenue−2.5%
$192.2M
2025 · hover or tap a bar for each year
2019: $110.0M2020: $116.6M (+6.0%)2021: $139.4M (+19.6%)2022: $165.0M (+18.3%)2023: $185.4M (+12.4%)2024: $197.2M (+6.4%)2025: $192.2M (−2.5%)
20192025
Gross profit−1.2%
$137.4M
2025 · hover or tap a bar for each year
2019: $66.4M2020: $71.6M (+7.9%)2021: $90.6M (+26.4%)2022: $110.4M (+21.9%)2023: $127.5M (+15.5%)2024: $139.1M (+9.1%)2025: $137.4M (−1.2%)
20192025
Operating income+12.5%
$35.6M
2025 · hover or tap a bar for each year
2019: $23.5M2020: $31.8M (+35.1%)2021: $34.6M (+8.7%)2022: −$60.7M (−275.7%)2023: $28.7M2024: $31.6M (+10.3%)2025: $35.6M (+12.5%)
20192025
Net income+756.7%
$27.0M
2025 · hover or tap a bar for each year
2019: $21.3M2020: $29.2M (+37.0%)2021: $32.6M (+11.9%)2022: −$969,000 (−103.0%)2023: $3.3M2024: $3.2M (−4.8%)2025: $27.0M (+756.7%)
20192025
EPS (diluted)−35.9%
$0.59
2025 · hover or tap a bar for each year
2020: $3.852021: $0.28 (−92.7%)2022: $0.42 (+50.0%)2023: −$0.21 (−150.0%)2024: $0.922025: $0.59 (−35.9%)
20192025
Net profit margin+12.5 pts
14.1%
2025 · hover or tap a point for each year
2019: 19.4%2020: 25.0% (+5.7 pts)2021: 23.4% (−1.6 pts)2022: −0.6% (−24.0 pts)2023: 1.8% (+2.4 pts)2024: 1.6% (−0.2 pts)2025: 14.1% (+12.5 pts)
20192025

BTMD revenue and net income

RevenueNet incomeNet margin (right axis)

Where BTMD's revenue goes

2025
Revenue
$192.2M100.0%
Cost of revenue
−$54.9M−28.5%
Gross profit
$137.4M71.5%
Sales, general & admin
−$101.8M−53.0%
Operating income
$35.6M18.5%
Interest & other income
$2.0M1.1%
Income taxes
−$6.0M−3.1%
Net income
$27.0M14.1%

Each bar shows an amount and its share of revenue. BTMD kept 14.1% of revenue as net income.

BTMD profit margins

GrossOperatingNet

BTMD growth rates

to 2025
1 year3 years5 years10 years
Revenue−2.5%+5.2%+10.5%—
Gross profit−1.2%+7.6%+13.9%—
Operating income+12.5%—+2.3%—
Net income+756.7%—−1.5%—
EPS (diluted)−35.9%+12.0%−31.3%—

1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.

BTMD quarterly EPS vs estimates

Reported EPSAnalyst estimate

biote beat the analyst EPS estimate in 6 of the last 8 quarters. Next report: November 4, 2026 (estimate $-0.05).

BTMD income statement

biote Corp. annual income statement
2025202420232022202120202019
Revenue$192.2M$197.2M$185.4M$165.0M$139.4M$116.6M$110.0M
Cost of revenue$54.9M$58.1M$57.9M$54.6M$48.8M$44.9M$43.6M
Gross profit$137.4M$139.1M$127.5M$110.4M$90.6M$71.6M$66.4M
Sales, general & admin$101.8M$107.5M$93.4M$171.1M$54.0M$37.4M$39.3M
Total operating expenses$101.8M$107.5M$98.8M$171.1M$56.0M$39.9M$42.9M
Operating income$35.6M$31.6M$28.7M−$60.7M$34.6M$31.8M$23.5M
Interest expense$11.0M$11.0M$6.4M$4.0M$1.7M$2.4M$2.1M
Income before taxes$37.6M$1.0M−$123,000$1.7M$32.9M$29.4M$21.4M
Income taxes$6.0M$970,000$2.7M$388,000$286,000$189,000$93,000
Net income$27.0M$3.2M$3.3M−$969,000$32.6M$29.2M$21.3M
EBITDA$52.2M$15.6M$41.7M$8.0M$36.0M$32.9M$24.3M
EPS (diluted)$0.59$0.92−$0.21$0.42$0.28$3.85—
Gross margin71.5%70.5%68.8%66.9%65.0%61.5%60.4%
Operating margin18.5%16.0%15.5%−36.8%24.8%27.3%21.4%
Net margin14.1%1.6%1.8%−0.6%23.4%25.0%19.4%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in BTMD's financial statements (latest annual report filed March 13, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.

BTMD financial results

In fiscal year 2025 (ended December 31, 2025), biote reported revenue of $192.2 million, down 2.5% from the year before. It had net income of $27.0 million (up 756.7%), a net profit margin of 14.1%. Diluted earnings per share came to $0.59. Over five years revenue grew at an average rate of 10.5% a year.

See the BTMD stock overview for the latest quote and news, or the BTMD chart for price history and technical indicators.

BTMD income statement FAQ

What is biote's annual revenue?

biote reported total revenue of $192.2 million for fiscal year 2025, which ended on December 31, 2025. That was down 2.5% from $197.2 million the previous year.

Is biote profitable?

Yes. biote reported net income of $27.0 million in fiscal 2025, a net profit margin of 14.1%; its operating margin was 18.5%.

What is biote's gross margin?

biote's gross margin was 71.5% in fiscal 2025: for every $100 of revenue, biote kept $71 after the direct cost of its products and services.

How fast is biote growing?

Revenue grew 10.5% a year on average over the last five fiscal years, from $116.6 million to $192.2 million.

What are biote's earnings per share?

biote earned $0.59 per diluted share in fiscal 2025, compared with $0.92 a year earlier.

When will biote report its next earnings?

biote is expected to report results for the quarter ending September 30, 2026 on November 4, 2026 after the market closes.

When does biote's fiscal year end?

biote's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on March 13, 2026.

Medical Care Facilities income statements